Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1992 Oct;36(10):2069–2074. doi: 10.1128/aac.36.10.2069

Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis.

A C Cremieux 1, C Carbon 1
PMCID: PMC245457  PMID: 1444286

Full text

PDF
2069

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Archer G., Fekety F. R., Jr Experimental endocarditis due to Pseudomonas aeruginosa. II. Therapy with carbenicillin and gentamicin. J Infect Dis. 1977 Sep;136(3):327–335. doi: 10.1093/infdis/136.3.327. [DOI] [PubMed] [Google Scholar]
  2. Barza M., Brusch J., Bergeron M. G., Weinstein L. Penetration of antibiotics into fibrin loci in vivo. 3. Intermittent vs. continuous infusion and the effect of probenecid. J Infect Dis. 1974 Jan;129(1):73–78. doi: 10.1093/infdis/129.1.73. [DOI] [PubMed] [Google Scholar]
  3. Barza M., Weinstein L. Penetration of antibiotics into fibrin loci in vivo. I. Comparison of penetration of ampicillin into fibrin clots, abscesses, and "interstitial fluid". J Infect Dis. 1974 Jan;129(1):59–65. doi: 10.1093/infdis/129.1.59. [DOI] [PubMed] [Google Scholar]
  4. Bayer A. S., Crowell D., Nast C. C., Norman D. C., Borrelli R. L. Intravegetation antimicrobial distribution in aortic endocarditis analyzed by computer-generated model. Implications for treatment. Chest. 1990 Mar;97(3):611–617. doi: 10.1378/chest.97.3.611. [DOI] [PubMed] [Google Scholar]
  5. Bayer A. S., Selecky M., Babel K., Hirano L., Yih J., Parr T. R., Jr Bactericidal interactions of a beta-lactam and beta-lactamase inhibitors in experimental Pseudomonas aeruginosa endocarditis caused by a constitutive overproducer of type Id beta-lactamase. Antimicrob Agents Chemother. 1987 Nov;31(11):1750–1755. doi: 10.1128/aac.31.11.1750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brook I. Inoculum effect. Rev Infect Dis. 1989 May-Jun;11(3):361–368. doi: 10.1093/clinids/11.3.361. [DOI] [PubMed] [Google Scholar]
  7. Carbon C. Impact of the antibiotic dosage schedule on efficacy in experimental endocarditis. Scand J Infect Dis Suppl. 1990;74:163–172. [PubMed] [Google Scholar]
  8. Caron F., Gutmann L., Bure A., Pangon B., Vallois J. M., Pechinot A., Carbon C. Ceftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamase. Antimicrob Agents Chemother. 1990 Nov;34(11):2070–2074. doi: 10.1128/aac.34.11.2070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Carrizosa J., Levison M. E. Minimal concentrations of aminoglycoside that can synergize with penicillin in enterococcal endocarditis. Antimicrob Agents Chemother. 1981 Sep;20(3):405–409. doi: 10.1128/aac.20.3.405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chambers H. F., Kennedy S. Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis. Antimicrob Agents Chemother. 1990 Apr;34(4):510–514. doi: 10.1128/aac.34.4.510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Contrepois A., Joly V., Abel L., Pangon B., Vallois J. M., Carbon C. The pharmacokinetics and extravascular diffusion of teicoplanin in rabbits and comparative efficacy with vancomycin in an experimental endocarditis model. J Antimicrob Chemother. 1988 May;21(5):621–631. doi: 10.1093/jac/21.5.621. [DOI] [PubMed] [Google Scholar]
  12. Contrepois A., Vallois J. M., Garaud J. J., Pangon B., Mohler J., Meulemans A., Carbon C. Kinetics and bactericidal effect of gentamicin and latamoxef (moxalactam) in experimental Escherichia coli endocarditis. J Antimicrob Chemother. 1986 Feb;17(2):227–237. doi: 10.1093/jac/17.2.227. [DOI] [PubMed] [Google Scholar]
  13. Costerton J. W., Lambe D. W., Jr, Mayberry-Carson K. J., Tober-Meyer B. Cell wall alterations in staphylococci growing in situ in experimental osteomyelitis. Can J Microbiol. 1987 Feb;33(2):142–150. doi: 10.1139/m87-025. [DOI] [PubMed] [Google Scholar]
  14. Cozens R. M., Tuomanen E., Tosch W., Zak O., Suter J., Tomasz A. Evaluation of the bactericidal activity of beta-lactam antibiotics on slowly growing bacteria cultured in the chemostat. Antimicrob Agents Chemother. 1986 May;29(5):797–802. doi: 10.1128/aac.29.5.797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cremieux A. C., Maziere B., Vallois J. M., Ottaviani M., Azancot A., Raffoul H., Bouvet A., Pocidalo J. J., Carbon C. Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography. J Infect Dis. 1989 May;159(5):938–944. doi: 10.1093/infdis/159.5.938. [DOI] [PubMed] [Google Scholar]
  16. Crémieux A. C., Mazière B., Vallois J. M., Ottaviani M., Bouvet A., Pocidalo J. J., Carbon C. Ceftriaxone diffusion into cardiac fibrin vegetation. Qualitative and quantitative evaluation by autoradiography. Fundam Clin Pharmacol. 1991;5(1):53–60. doi: 10.1111/j.1472-8206.1991.tb00701.x. [DOI] [PubMed] [Google Scholar]
  17. Dall L., Barnes W. G., Lane J. W., Mills J. Enzymatic modification of glycocalyx in the treatment of experimental endocarditis due to viridans streptococci. J Infect Dis. 1987 Nov;156(5):736–740. doi: 10.1093/infdis/156.5.736. [DOI] [PubMed] [Google Scholar]
  18. Drusano G. L. Role of pharmacokinetics in the outcome of infections. Antimicrob Agents Chemother. 1988 Mar;32(3):289–297. doi: 10.1128/aac.32.3.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Durack D. T., Beeson P. B. Experimental bacterial endocarditis. II. Survival of a bacteria in endocardial vegetations. Br J Exp Pathol. 1972 Feb;53(1):50–53. [PMC free article] [PubMed] [Google Scholar]
  20. Durack D. T. Experimental bacterial endocarditis. IV. Structure and evolution of very early lesions. J Pathol. 1975 Feb;115(2):81–89. doi: 10.1002/path.1711150204. [DOI] [PubMed] [Google Scholar]
  21. Fantin B., Carbon C. In vivo antibiotic synergism: contribution of animal models. Antimicrob Agents Chemother. 1992 May;36(5):907–912. doi: 10.1128/aac.36.5.907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Fantin B., Pangon B., Potel G., Caron F., Vallée E., Vallois J. M., Mohler J., Buré A., Philippon A., Carbon C. Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase. Antimicrob Agents Chemother. 1990 Apr;34(4):581–586. doi: 10.1128/aac.34.4.581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Fantin B., Pangon B., Potel G., Vallois J. M., Caron F., Bure A., Carbon C. Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis. Antimicrob Agents Chemother. 1989 May;33(5):767–770. doi: 10.1128/aac.33.5.767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Farber B. F., Kaplan M. H., Clogston A. G. Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of glycopeptide antibiotics. J Infect Dis. 1990 Jan;161(1):37–40. doi: 10.1093/infdis/161.1.37. [DOI] [PubMed] [Google Scholar]
  25. Felmingham D., Solomonides K., O'Hare M. D., Wilson A. P., Grüneberg R. N. The effect of medium and inoculum on the activity of vancomycin and teicoplanin against coagulase-negative staphylococci. J Antimicrob Chemother. 1987 Oct;20(4):609–610. doi: 10.1093/jac/20.4.609. [DOI] [PubMed] [Google Scholar]
  26. Franciolli M., Bille J., Glauser M. P., Moreillon P. Beta-lactam resistance mechanisms of methicillin-resistant Staphylococcus aureus. J Infect Dis. 1991 Mar;163(3):514–523. doi: 10.1093/infdis/163.3.514. [DOI] [PubMed] [Google Scholar]
  27. Frehel C., Hellio R., Cremieux A. C., Contrepois A., Bouvet A. Nutritionally variant streptococci develop ultrastructural abnormalities during experimental endocarditis. Microb Pathog. 1988 Apr;4(4):247–255. doi: 10.1016/0882-4010(88)90085-x. [DOI] [PubMed] [Google Scholar]
  28. Garrison P. K., Freedman L. R. Experimental endocarditis I. Staphylococcal endocarditis in rabbits resulting from placement of a polyethylene catheter in the right side of the heart. Yale J Biol Med. 1970 Jun;42(6):394–410. [PMC free article] [PubMed] [Google Scholar]
  29. Gengo F. M., Mannion T. W., Nightingale C. H., Schentag J. J. Integration of pharmacokinetics and pharmacodynamics of methicillin in curative treatment of experimental endocarditis. J Antimicrob Chemother. 1984 Dec;14(6):619–631. doi: 10.1093/jac/14.6.619. [DOI] [PubMed] [Google Scholar]
  30. Gengo F. M., Schentag J. J. Rate of methicillin penetration into normal heart valve and experimental endocarditis lesions. Antimicrob Agents Chemother. 1982 Mar;21(3):456–459. doi: 10.1128/aac.21.3.456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Gilbert D. N., Wood C. A., Kimbrough R. C. Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon. Antimicrob Agents Chemother. 1991 Jan;35(1):79–87. doi: 10.1128/aac.35.1.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Glauser M. P., Neftel K. A. Toxicologic and pharmacologic considerations in the choice of empiric parenteral antibiotics. Am J Med. 1986 May 30;80(5C):64–69. [PubMed] [Google Scholar]
  33. Hessen M. T., Pitsakis P. G., Levison M. E. Absence of a postantibiotic effect in experimental Pseudomonas endocarditis treated with imipenem, with or without gentamicin. J Infect Dis. 1988 Sep;158(3):542–548. doi: 10.1093/infdis/158.3.542. [DOI] [PubMed] [Google Scholar]
  34. Ingerman M. J., Pitsakis P. G., Rosenberg A. F., Levison M. E. The importance of pharmacodynamics in determining the dosing interval in therapy for experimental pseudomonas endocarditis in the rat. J Infect Dis. 1986 Apr;153(4):707–714. doi: 10.1093/infdis/153.4.707. [DOI] [PubMed] [Google Scholar]
  35. Joly V., Bergeron Y., Bergeron M. G., Carbon C. Endotoxin-tobramycin additive toxicity on renal proximal tubular cells in culture. Antimicrob Agents Chemother. 1991 Feb;35(2):351–357. doi: 10.1128/aac.35.2.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Joly V., Pangon B., Vallois J. M., Abel L., Brion N., Bure A., Chau N. P., Contrepois A., Carbon C. Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis. Antimicrob Agents Chemother. 1987 Oct;31(10):1632–1639. doi: 10.1128/aac.31.10.1632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Kaatz G. W., Seo S. M., Barriere S. L., Albrecht L. M., Rybak M. J. Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother. 1990 Feb;34(2):257–260. doi: 10.1128/aac.34.2.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Koskiniemi M., Vaheri A., Taskinen E. Cerebrospinal fluid alterations in herpes simplex virus encephalitis. Rev Infect Dis. 1984 Sep-Oct;6(5):608–618. doi: 10.1093/clinids/6.5.608. [DOI] [PubMed] [Google Scholar]
  39. Lavoie G. Y., Bergeron M. G. Influence of four modes of administration on penetration of aztreonam, cefuroxime, and ampicillin into interstitial fluid and fibrin clots and on in vivo efficacy against Haemophilus influenzae. Antimicrob Agents Chemother. 1985 Sep;28(3):404–412. doi: 10.1128/aac.28.3.404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Leggett J. E., Fantin B., Ebert S., Totsuka K., Vogelman B., Calame W., Mattie H., Craig W. A. Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models. J Infect Dis. 1989 Feb;159(2):281–292. doi: 10.1093/infdis/159.2.281. [DOI] [PubMed] [Google Scholar]
  41. Lorian V., Zak O., Kunz S., Vaxelaire J. Staphylococcal endocarditis in rabbits treated with a low dose of cloxacillin. Antimicrob Agents Chemother. 1984 Mar;25(3):311–315. doi: 10.1128/aac.25.3.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. McColm A. A., Ryan D. M. Comparative pharmacokinetics of ceftazidime in fibrin clots and cardiac vegetations in rabbits with Staphylococcus aureus endocarditis. Antimicrob Agents Chemother. 1985 Jun;27(6):925–927. doi: 10.1128/aac.27.6.925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. McColm A. A., Ryan D. M. Penetration of beta-lactam antibiotics into cardiac vegetations, aorta and heart muscle in experimental Staphylococcus aureus endocarditis: comparison of ceftazidime, cefuroxime and methicillin. J Antimicrob Chemother. 1985 Sep;16(3):349–358. doi: 10.1093/jac/16.3.349. [DOI] [PubMed] [Google Scholar]
  44. NATHANSON M. H., LIEBHOLD R. A. Studies relative to the chemotherapy of bacterial endocarditis. Ann Intern Med. 1950 Nov;33(5):1224–1231. doi: 10.7326/0003-4819-33-5-1224. [DOI] [PubMed] [Google Scholar]
  45. Potel G., Chau N. P., Pangon B., Fantin B., Vallois J. M., Faurisson F., Carbon C. Single daily dosing of antibiotics: importance of in vitro killing rate, serum half-life, and protein binding. Antimicrob Agents Chemother. 1991 Oct;35(10):2085–2090. doi: 10.1128/aac.35.10.2085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Powell S. H., Thompson W. L., Luthe M. A., Stern R. C., Grossniklaus D. A., Bloxham D. D., Groden D. L., Jacobs M. R., DiScenna A. O., Cash H. A. Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin. J Infect Dis. 1983 May;147(5):918–932. doi: 10.1093/infdis/147.5.918. [DOI] [PubMed] [Google Scholar]
  47. Rouse M. S., Wilcox R. M., Henry N. K., Steckelberg J. M., Wilson W. R. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis. Antimicrob Agents Chemother. 1990 Feb;34(2):273–276. doi: 10.1128/aac.34.2.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Scheld W. M. Therapy of streptococcal endocarditis: correlation of animal model and clinical studies. J Antimicrob Chemother. 1987 Sep;20 (Suppl A):71–85. doi: 10.1093/jac/20.suppl_a.71. [DOI] [PubMed] [Google Scholar]
  49. Tebas P., Martinez Ruiz R., Roman F., Mendaza P., Rodriguez Diaz J. C., Daza R., de Letona J. M. Early resistance to rifampin and ciprofloxacin in the treatment of right-sided Staphylococcus aureus endocarditis. J Infect Dis. 1991 Jan;163(1):204–205. doi: 10.1093/infdis/163.1.204-a. [DOI] [PubMed] [Google Scholar]
  50. Thauvin C., Eliopoulos G. M., Willey S., Wennersten C., Moellering R. C., Jr Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats. Antimicrob Agents Chemother. 1987 Feb;31(2):139–143. doi: 10.1128/aac.31.2.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Vogelman B., Gudmundsson S., Leggett J., Turnidge J., Ebert S., Craig W. A. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J Infect Dis. 1988 Oct;158(4):831–847. doi: 10.1093/infdis/158.4.831. [DOI] [PubMed] [Google Scholar]
  52. Vogelman B., Gudmundsson S., Turnidge J., Leggett J., Craig W. A. In vivo postantibiotic effect in a thigh infection in neutropenic mice. J Infect Dis. 1988 Feb;157(2):287–298. doi: 10.1093/infdis/157.2.287. [DOI] [PubMed] [Google Scholar]
  53. WEINSTEIN L., DAIKOS G. K., PERRIN T. S. Studies on the relationship of tissue fluid and blood levels of penicillin. J Lab Clin Med. 1951 Nov;38(5):712–718. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES